doi: 10.3389/fmolb.2025.1622186 Received 02 May 2025 Accepted 02 June 2025 Published 26 June 2025 Volume 12 - 2025 Edited by Roberta Marongiu, Cornell University, United States Reviewed by Larance Ronsard, Ragon Institute, United States Jorge Felipe Argenta Model, Federal University of Rio Grande do Sul, Brazil Updates Copyright 2025 Lizcano, Sanabria and Aviles
Even subtle shifts suggest the GIP pathway is engaging
Jordan has seen the effect in patients at Midi: We had a patient who took GLP-1s to lose weight, but the drug also helped her to quit smoking
holds shares in Genetta Soft AB, a Swedish company devoted to bioinformatics software
The efficacy of semaglutide, tirzepatide, and retatrutide in treating obesity may be promising for patients with POMC-MC4R pathway deficiency
By partnering with our skilled team and embracing comprehensive lifestyle improvements, you can achieve lasting weight loss results and long-term health enhancements